Perirenal perivascular epithelioid cell tumor (PEComa)

Virginie CampsDepartment of Abdominal Surgery, H. Hart hospital, Mol, BelgiumCorrespondence[email protected] [email protected]

Vicky MaertensDepartment of Abdominal Surgery, H. Hart hospital, Mol, Belgium

Maarten MichielsDepartment of Abdominal Surgery, H. Hart hospital, Mol, Belgium

Herbert PlasschaertDepartment of Abdominal Surgery, H. Hart hospital, Mol, Belgium

Robrecht CeulemansDepartment of Abdominal Surgery, H. Hart hospital, Mol, Belgium

References

Danilewicz M, Strzelczyk JM, Wagrowska-Danilewicz M. Perirenal perivascular epithelioid cell tumor (PEComa) coexisting with other malignancies: a case report. Pol J Pathol. 2017;68(1):92–95.
PubMed Web of Science ®Google Scholar
Singer E, Yau S, Johnson M. Retroperitoneal PEComa: case report and review of literature. Urol Case Rep. 2018;19:9–10.
PubMed Web of Science ®Google Scholar
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29(12):1558–1575.
PubMed Web of Science ®Google Scholar
Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34(5):715–722.
PubMed Web of Science ®Google Scholar
Kalyanasundaram K, Parameswaran A, Mani R. Perivascular epithelioid tumor of urinary bladder and vagina. Ann Diagn Pathol. 2005;9(5):275–278.
PubMedGoogle Scholar
Rigby H, Yu W, Schmidt MH, et al. Lack of response of a metastatic renal perivascular epithelial cell tumor (PEComa) to successive courses of DTIC based-therapy and imatinib mesylate. Pediatr Blood Cancer. 2005;45(2):202–206.
PubMed Web of Science ®Google Scholar